腫瘍病理鑑別診断アトラス　肺癌

出版社： 文光堂
著者：
発行日： 2014-11-13
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830622410
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2014-11-13 （第1版第3刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

16,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

新WHO分類，改訂取扱い規約を先取りし，肺癌病理の新たな動きをしっかりととらえ，多彩な上皮性腫瘍，間葉系腫瘍，腫瘍様病変を識別する海図・羅針盤の役割を果たす一冊．

目次

  • 腫瘍病理鑑別診断アトラス　肺癌

    ―目次―

    第１部　検鏡前の確認事項
    　I．肺癌取扱い規約のコンセプト
    　II．病理標本の取扱い方

    第２部　組織型と診断の実際
    　I．上皮性腫瘍
    　II．非上皮性腫瘍
    　III．リンパ組織増殖性疾患
    　IV．二次性腫瘍：転移性肺腫瘍
    　V．腫瘍様病変

    第３部　鑑別ポイント
    　I．低分化な癌の鑑別（腺癌か，扁平上皮癌か）
    　II．迅速診断で浸潤性肺腺癌と鑑別を要する病変
    　III．腺癌浸潤の判定，浸潤部の測定の実際
    　IV．縦隔側の胸膜浸潤
    　V．転移性肺癌の鑑別

    第４部　臨床との連携
    　I．画像診断：主として術前画像との比較
    　II．細胞診の有用性
    　III．治療
    　IV．病理診断報告書の記載

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.3 掲載の参考文献
1) 日本肺癌学会 (編) : 肺癌取扱い規約, 第1版, 金原出版, 1978
 
2) 日本肺癌学会 (編) : 肺癌取扱い規約, 第2版, 金原出版, 1982
 
3) 日本肺癌学会 (編) : 肺癌取扱い規約, 第4版, 金原出版, 1995
 
4) 日本肺癌学会 (編) : 肺癌取扱い規約, 第5版, 金原出版, 1999
 
5) Travis WD, Brambilla E, Corrin B, et al (eds) : Histological Typing of Lung and Pleural Tumours, Springer, Berlin, 1999
 
6) 日本肺癌学会 (編) : 肺癌取扱い規約, 第6版, 金原出版, 2003
 
7) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, IARC Press, Lyon, 2004
 
8) 日本肺癌学会 (編) : 肺癌取扱い規約, 第7版, 金原出版, 2010
 
P.6 掲載の参考文献
1) WHO : Histological Typing of Lung Tumours, World Health Organization (WHO), Geneva, 1981
 
2) Hansen HH : History of the IASLC, Rx Press, Orange Park, 2009, pp35-40
 
3) Travis WD, Colby TV, Corrin B, et al (eds) : Histological Typing of Lung and Pleural Tumours, Springer, Berlin, 1999
 
4) Travis WD, Brambilla E, Muller-Hermelink HK, et al : WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, IARC Press, Lyon, 2004
 
5) Travis WD, Brambilla E, Noguchi M, et al : International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thoracic Oncol 6 : 244-285, 2011
 
6) Noguchi M, Morikawa A, Kawasaki M, et al : Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 : 2844-2852, 1995
PubMed
7) Minami Y, Matsuno Y, Iijima T, et al : Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer 48 : 339-348, 2005
PubMed
8) Miyoshi T, Satoh Y, Okumura S, et al : Early-stage lung adenocarcinoma with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 27 : 101-109, 2003
PubMed
9) Nakazato Y, Maeshima AM, Ishikawa Y, et al : Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma. J Thoracic Oncol 8 : 736-743, 2013
 
P.8 掲載の参考文献
1) 山中晃, 横山武 : (付 II) 肺の病理学的検索法. 肺病理アトラス-呼吸器疾患の立体的理解のために, 文光堂, 1985, pp238-239
 
2) 児玉哲郎 : 癌の生検診断-とくに境界病変の鑑別と処置-気管・気管支・肺・胸膜ならびに縦隔. 病理と臨床 1 : 21-31, 1983
 
3) 日本肺癌学会 : 肺癌患者におけるEGFR遺伝子変異検査の解説. (日本肺癌学会ホームページ : 各種ガイドライン http//www.haigan.gr.jp)
 
4) 日本肺癌学会 : 肺癌患者におけるALK遺伝子検査の手引き. (日本肺癌学会ホームページ : 各種ガイドライン http//www.haigan.gr.jp)
 
P.17 掲載の参考文献
1) 下里幸雄, 井内康輝 (編) : 腫瘍鑑別診断アトラス 肺, 第2版, 文光堂, 2004
 
2) びまん性肺疾患研究会 (編) : びまん性肺疾患の臨床-診断・管理・治療と症例, 第4版, 金芳堂, 2012
 
3) Hsu PK, Huang HC, Hsieh CC, et al : Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. Ann Thorac Surg 84 : 1825-1829, 2007
 
4) 日本肺癌学会 (編) : 肺癌取扱い規約, 第7版, 金原出版, 2010
 
5) Hitchman E, Hodgkinson C, Roberts D, et al : Effect of prolonged formalin fixation on immunohistochemical staining for the proliferation marker Ki67. Histopathology 59 : 1261-1263, 2011
PubMed
6) von Ahlfen S, Missel A, Bendrat K, et al : Determinants of RNA quality from FFPE samples. PLoS One 2 : e1261, 2007
PubMed
7) 外科病理マニュアル, 病理と臨床 26 (臨増), 2008
 

第2部 組織型と診断の実際

P.22 掲載の参考文献
1) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours. Pathology and Genetics : Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004
 
2) Tryfon S, Dramba V, Zoglopitis F, et al : Solitary papillomas of the lower airways : epidemiological, clinical, and therapeutic data during a 22-year period and review of the literature. J Thorac Oncol 7 : 643-648, 2012
PubMed
3) Flieder DB, Koss MN, Nicholson A, et al : Solitary pulmonary papillomas in adults : a clinicopathologic and in situ hybridization study of 14 cases combined with 27 cases in the literature. Am J Surg Pathol 22 : 1328-1342, 1998
PubMed
4) Popper HH, el-Shabrawi Y, Wockel W, et al : Prognostic importance of human papilloma virus typing in squamous cell papilloma of the bronchus : comparison of in situ hybridization and the polymerase chain reaction. Hum Pathol 25 : 1191-1197, 1994
PubMed
P.28 掲載の参考文献
1) Yousem SA, Hochholzer L : Alveolar adenoma. Hum Pathol 17 : 1066-1071, 1986
PubMed
2) Roque L, Oliveira P, Martins C, et al : A nonbalanced translocation (10 ; 16) demonstrated by FISH analysis in a case of alveolar adenoma of the lung. Cancer Genet Cytogenet 89 : 34-37, 1996
 
3) Hamid Kazerouni A, Chetty Runjan : Alveolar adenoma of the lung. Diagnostic Histopathology 19 : 311-313, 2013
 
4) Sak SD, Koseoglu RD, Demirag F, et al : Alveolar adenoma of the lung. Immunohistochemical and flow cytometric characteristics of two new cases and a review of the literature. APMIS 115 : 1443-1449, 2007
 
5) De Rosa N, Maiorino A, De Rosa I, et al : CD34 Expression in the stromal cells of alveolar adenoma. Case Rep Med 2012 : 913517, 2012
PubMed
6) Spencer H, Dail DH, Arneaud J : Non-invasive bronchial epithelial papillary tumors. Cancer 45 : 1486-1497, 1980
PubMed
7) Nakano T, Yokose T, Hasegawa C, et al : Papillary adenoma of the lung with a peculiar raw macroscopic feature. Pathol Int 61 : 475-480, 2011
PubMed
8) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004
 
9) Allen TC, Amrikachi M, Cagle PT : Pulmonary sclerosing papillary adenoma. Pathol Int 63 : 364-367, 2013
PubMed
10) Mori M, Chiba R, Tezuka F, et al : Papillary adenoma of type II pneumocytes might have malignant potential. Virchows Arch 428 : 195-200, 1996
PubMed
11) Spencer H : Bronchial mucous gland tumours. Virchows Arch A Pathol Anat Histol 383 : 101-115, 1979
PubMed
12) Gaissert HA, Mark EJ : Tracheobronchial gland tumors. Cancer Control 13 : 286-294, 2006
PubMed
13) Couraud S, Isaac S, Guibert B, et al : Bronchial mucous gland adenoma revealed following acute pneumonia. Interact Cardiovasc Thorac Surg 14 : 347-349, 2012
PubMed
14) Achcar Rde O, Nikiforova MN, Dacic S, et al : Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. Hum Pathol 40 : 854-860, 2009
PubMed
15) Moran CA, Suster S, Askin FB, et al : Benign and malignant salivary gland-type mixed tumors of the lung. Clinicopathologic and immunohistochemical study of eight cases. Cancer 73 : 2481-2490, 1994
PubMed
16) Kragel PJ, Devaney KO, Meth BM, et al : Mucinous cystadenoma of the lung. A report of two cases with immunohistochemical and ultrastructural analysis. Arch Pathol Lab Med 114 : 1053-1056, 1990
 
17) Gao ZH, Urbanski SJ : The spectrum of pulmonary mucinous cystic neoplasia : a clinicopathologic and immunohistochemical study of ten cases and review of literature. Am J Clin Pathol 124 : 62-70, 2005
PubMed
18) Moran CA, Suster S : Tumors and Tumor-like Conditions of the Lung and Pleura. Saunders/Elsevier, Philadephia, 2010
 
P.35 掲載の参考文献
1) Hammer SP, Brambilla C, Pugatch B, et al : Squamous cell carcinoma. in Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : "WHO Classification of Tumours Pathology and Genetics, Tumours of the Lung, Pleura, Thumus and Heart", IARC Press, Lyon, 2004, pp26-30
 
2) 日本肺癌学会 (編) : 肺癌取扱い規約, 第7版, 金原出版, 2010, pp70-76
 
3) Auerbach O, Gere JB, Forma JB, et al : Changes in the bronchial epithelium in relation to smoking and cancer of the lung ; a report of progress. N Engl J Med 256 : 97-104, 1957
 
4) Hoshino H, Shibuya K, Chiyo M, et al : Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy. Lung Cancer 46 : 187-196, 2004
PubMed
5) Breuer RH, Pasic A, Smitt EF, et al : The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 11 : 537-543, 2005
 
6) Keith RL, Miller YE, Gemmill RM, et al : Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res 6 : 1616-1625, 2000
PubMed
7) Kerr KM : Pulmonary pre-invasive disease. in Hasleton P, Flieder DB (eds) : "Spencer's Pathology of the Lung", 6th ed, Vol II, Cambridge University Press, Cambridge, 2013, pp889-944
 
8) Wistuba II, Behrens C, Virmani AK, et al : High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60 : 1949-1960, 2000
PubMed
9) 西阪隆, 井内康輝 : 病理・分子生物学 中枢気管支上皮の過形成性病変の多様性と発がん母地としての意義. 加藤治文他 (編) : MOOK肺癌の臨床 2008-2009, 篠原出版新社, 2008, pp67-76
 
10) Kerr KM, Fraire AE : Preinvasive disease. in Tomashefski JF (ed) : "Dail and Hammar's Pulmonary Pathology", 3rd ed, Vol II, Neoplastic Lung Disease, Springer, New York, 2008, pp176-178
 
11) Franklin WA, Veve R, Hirsch FR, et al : Epidermal growth factor receptor family in lung cancer and malignancy. Semin Oncol 29 : 3-14, 2002
 
12) Rusch V, Klimstra D, Linkov I, et al : Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Cancer Res 55 : 1365-1372, 1995
PubMed
P.41 掲載の参考文献
1) Travis WD, Colby TV, Corrin B, et al (eds) : Histological Typing of Lung and Pleural Tumours, Springer, Berlin, 1999
 
2) Travis WD, Brambilla E, Noguchi M, et al : International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thoracic Oncol 6 : 244-285, 2011
 
3) Yokose T, Doi M, Tanno K, et al : Atypical adenomatous hyperplasia of the lung in autopsy cases. Lung Cancer 33 : 155-161, 2001
PubMed
4) Yokose T, Ito Y, Ochiai A : High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. Lung Cancer 29 : 125-130, 2000
PubMed
5) Kerr KM : Pulmonary preinvasive neoplasia. J Clin Pathol 54 : 257-271, 2001
PubMed
6) Ullmann R, Bongiovanni M, Halbwedl I, et al : Is highgrade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma? J Pathol 201 : 371-376, 2003
PubMed
7) Minami Y, Matsuno Y, Iijima T, et al : Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer 48 : 339-348, 2005
PubMed
8) Nakayama H, Noguchi M, Tsuchiya R, et al : Clonal growth of atypical adenomatous hyperplasia of the lung : cytofluorometric analysis of nuclear DNA content. Mod Pathol 3 : 314-320, 1990
PubMed
9) Sakamoto H, Shimizu J, Horio Y, et al : Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol 212 : 287-294, 2007
PubMed
10) Hashizume T, Yamada K, Okamoto N, et al : Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinoma. Chest 133 : 441-447, 2008
PubMed
11) Goldstraw P (ed) : Staging Manual in Thoracic Oncology, Editorial Rx Press, Orange Park, 2009
 
12) Jones KD : Whence Lepidic? The history of a Canadian neologism. Arch Pathol Lab Med 137 : 1822-1824, 2013
PubMed
13) Noguchi M, Morikawa A, Kawasaki M, et al : Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 : 2844-2852,1995
PubMed
14) Yim J, Zhu LC, Chiriboga L, et al : Histologic features are important prognostic indicators in early stage lung adenocarcinomas. Modern Pathol 20 : 233-241, 2007
 
P.44 掲載の参考文献
1) Ruffini E, Bongiovanni M, Cavallo A, et al : The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms. Eur J Cardiothorac Surg 26 : 165-172, 2004
PubMed
2) Aguayo SM, Miller YE, Waldron JA Jr, et al : Brief report : idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 327 : 1285-1288, 1992
PubMed
3) Davies SJ, Gosney JR, Hansell DM, et al : Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia : an underrecognised spectrum of disease. Thorax 62 : 248-252, 2007
PubMed
P.54 掲載の参考文献
1) Hammer SP, Brambilla C, Pugatch B, et al : Squamous cell carcinoma. in Travis WD, et al (eds) : "WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thumus and Heart", IARC Press, Lyon, 2004, pp26-30
 
2) 日本肺癌学会 (編) : 肺癌取扱い規約, 第7版, 金原出版, 2010, pp72-73
 
3) Davis WD, Lubin J, Ries L, et al : United States lung carcinoma trend. Cancer 77 : 2464-2470, 1996
 
4) 井内康輝 : 肺扁平上皮癌の組織診断. 病理と臨床 28 : 145-150, 2010
Medical*Online
5) Khunder SA : Effect of cigarette smoking on major histological types of lung cancer : a meta-analysis. Lung Cancer 31 : 139-148, 2001
 
6) Auerbach O, Gerfinker L : The changing pattern of lung carcinoma. Cancer 68 : 1973-1977, 1991
 
7) Funai K, Yokose T, Ishii G, et al : Clincopathological characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol 27 : 978-984, 2003
 
8) Colby TV, Koss MN, Travis WD : Tumors of the Lower Respiratory Tract, 3rd ed, Armed Forces Institute of Pathology, Washington DC, 1995, pp107-134
 
9) Travis WD, Travis LB, Devesa SS : Lung cancer. Cancer 75 : 191-202, 1995
PubMed
10) Goldstraw P : Lung. in Edge SB, et al (eds) : "AJCC Cancer Staging Manual", Springer-Verlag, New York, 2010, pp253-270
 
11) 日本肺癌学会 (編) : 内視鏡所見分類. 肺癌取扱い規約, 第7版, 金原出版, 2010, pp149-162
 
12) Yousen SA : Peripheral squamous cell carcinoma of lung : patterns of growth with particular focus on airspace filling. Hum Pathol 40 : 861-867, 2009
 
13) Watanabe Y, Yokose T, Sakuma Y, et al : Alveolar space filling ratio as a favorable prognostic factor in small peripheral squamous cell carcinoma of the lung. Lung Cancer 73 : 217-221, 2011
PubMed
14) Cakir E, Demirag F, Ucoluk GO, et al : Basaloid squamous cell carcinoma of the lung, a rare tumour with rare clinical presentation. Lung Cancer 57 : 109-111, 2007
 
15) Moro-Sibilot D, Lantuejoul S, Diab S, et al : Lung carcinomas with a basaloid pattern : s study of 90 cases focusing on their poor prognosis. Eur Respir J 31 : 854-859, 2008
 
16) Brambilla E, Moro D, Veale D, et al : Basal cell (basaloid) carcinoma of the lung : a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 23 : 993-1003, 1992
 
17) Sturm N, Lantuejoul S, Laverriere MH, et al : Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol 32 : 918-925, 2001
PubMed
18) 日本肺癌学会 (編) : 日本肺癌学会 肺癌診療ガイドライン-肺癌の病理・細胞診断ガイドライン. 2011, p16 (https://www.haigan.gr.jp/uploads/photos/321.pdf)
 
19) Cooper D, Schermer A, Sun T : Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins : strategies, application and limitations. Lab Invest 52 : 243-250, 1985
PubMed
20) Pelosi G, Pasini F, Sonzogni A, et al : Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Cancer 97 : 2487-2497, 2003
 
21) Bishop JA, Teruya-Feldstein J, Westra WH, et al : p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 25 : 405-415, 2012
 
22) Nonaka D : A study of ΔNp63 expression in lung nonsmall cell carcinomas. Am J Surg Pathol 9 : 895-899, 2012
 
23) Agackiran Y, Ozcan A, Akyurek N, et al : Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes. Appl Immunohistochem Mol Morphol 20 : 350-355, 2012
 
P.60 掲載の参考文献
1) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours. Pathology and Genetics, Tumours of the Lung, Pleura, Thymus and Heart, IARC Press, Lyon, 2004.
 
2) Bosman FT, Carneiro F, Hruban RH, et al (eds) : WHO Classification of Tumors of the Digestive System, 4th ed, IARC Press, Lyon, 2010
 
3) Hamanaka W, Motoi N, Ishikawa S, et al : A subset of small cell lung cancer with low neuroendocrine expression and good prognosis : a comparison study of surgical cases to inoperable cases with biopsy. Hum Pathol 45 : 1045-1056, 2014
 
P.63 掲載の参考文献
1) Travis WD, Linnoila RI, Tsokos MG, et al : Neuroendocrine tumors of the lung with proposed criteria for largecell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15 : 529-553, 1991
PubMed
2) Asamura H, Kameya T, Matsuno Y, et al : Neuroendocrine neoplasms of the lung : a prognostic spectrum. J Clin Oncol 24 : 70-76, 2006
 
3) Kenmotsu H, Niho S, Ito T, et al : A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer). Lung Cancer 84 : 254-258, 2014
 
4) Rossi G, Bisagni A, Cavazza A : High-grade neuroendocrine carcinoma. Curr Opin Pulm Med 20 : 332-339, 2014
PubMed
P.67 掲載の参考文献
1) Travis WD, Brambilla E, Noguchi M, et al : International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thoracic Oncol 6 : 244-285, 2011
 
2) Minami Y, Matsuno Y, Iijima T, et al : Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer 48 : 339-348, 2005
PubMed
P.75 掲載の参考文献
1) Lozano T, Naghavi M, Foreman K, et al : Global and regional mor tality from 235 causes of death for 20 age groups in 1990 and 2010 : a systemic analysis for the Global Burden of Disease Study 2010. Lancet 380 : 2095-2128, 2012
 
2) U.S. Depar tment of Health and Human Ser vice : The Health Consequences of Smoking-50 Years of Progress : A Report of the Surgeon General, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014
 
3) Nawa T, Nakagawa T, Mizoue T, et al : A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan. Lung Cancer 78 : 225-228, 2012
PubMed
4) Anami Y, Iijima T, Suzuki K, et al : Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis. J Thrac Oncol 4 : 951-958, 2009
 
5) National Lung Screening Trial Research Team : Reduced lung-cancer mor tality with low-dose computed tomographic screening. N Engl J Med 365 : 395-409, 2011
 
6) Choi YD, Han CW, Kim JH, et al : Effectiveness of sputum cytology using ThinPrep method for evaluation of lung cancer. Diagn Cytopathol 36 : 167-171, 2008
PubMed
7) Onozato ML, Kovach AE, Yeap BY, et al : Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis. Am J Surg Pathol 37 : 287-294, 2013
PubMed
8) Noguchi M, Shimosato Y : The development and progression of adenocarcinoma of the lung. Cancer Treat Res 72 : 131-142, 1995
PubMed
9) Morishita Y, Fukasawa M, Takeuchi M, et al : Small-sized adenocarcinoma of the lung. Cytologic characteristics and clinical behavior. Cancer 93 : 124-131, 2001
PubMed
10) Itoguchi N, Nakagawa T, Murata Y, et al : Immunocytochemical staining for stratifin and OCIAD2 in bronchial washing specimens increases sensitivity for diagnosis of lung cancer. Cytopathology 2014 (in press)
 
11) Travis WD, Colby TV, Corrin B, et al : Histological Typing of Lung and Pleural Tumours, Springer, Berlin, 1999
 
12) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : Pathology and Genetics, Tumours of the Lung, Pleura, Thymus and Heart, IARC Press, Lyon, 2004.
 
13) Higashiyama M, Kodama K, Yokouchi H, et al : Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma. Ann Thorac Surg 68 : 2069-2073, 1999
PubMed
14) Koga T, Hashimoto S, Sugio K, et al : Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma. Clin Cancer Res 7 : 1730-1738, 2001
PubMed
15) Kodama K, Higashiyama M, Yokouchi H, et al : Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 33 : 17-25, 2001
PubMed
16) Yim J, Zhu LC, Chiriboga L, et al : Histologic features are important prognostic indicators in early stages lung adenocarcinoma. Mod Pathol 20 : 233-241, 2007
PubMed
17) Leighl NB, Rekhtman N, Biermann WA, et al : Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors : American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Society for the Study of Lung Cancer/Association of Molecular Pathologists Guideline. J Clin Oncol, doi : 10.1200/JCO.2014.57.3055
 
18) Travis WD, Brambilla E, Noguchi M, et al : International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thoracic Oncol 6 : 244-285, 2011
 
19) Miyoshi T, Satoh Y, Okumura S, et al : Early-stage lung adenocarcinoma with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 27 : 101-109, 2003
PubMed
20) Nakazato Y, Maeshima AM, Ishikawa Y, et al : Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma. J Thorac Oncol 8 : 736-743, 2013
PubMed
21) Thunnissen E, Beasley MB, Borczuk AC, et al : Reproducibility of histological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol 25 : 1574-1583, 2012
PubMed
22) Montezuma D, Azevedo R, Lopes P, et al : A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens. Virchows Arch 463 : 749-754, 2013
 
23) Takeuchi T, Tomida S, Yatabe Y, et al : Expression profiledefined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 24 : 1679-1688, 2006
PubMed
24) Sugano M, Nagasaka T, Sasaki E, et al : HNF4a as a marker for invasive mucinous adenocarcinoma of the lung. Am J Surg Pathol 37 : 211-218, 2013
PubMed
25) Kamiya K, Hayashi Y, Douguchi J, et al : Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma. Mod Pathol 21 : 992-1001, 2008
PubMed
26) Nakazato Y, Minami Y, Kobayashi H, et al : Nuclear grading of primary pulmonary adenocarcinoma. Cancer 116 : 2011-2019, 2010
PubMed
27) Travis WD, Brambilla E, Noguchi M, et al : Diagnosis of lung cancer in small biopsies and cytology. Implication of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification. Arch Pathol Lab Med 137 : 668-684, 2013
 
P.79 掲載の参考文献
1) Tsuta K, Kawago M, Inoue E, et al : The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 81 : 371-376, 2013
PubMed
2) Sakuma Y, Matsukuma S, Yoshihara M, et al : Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas : confirmation of the correlations with histologic subtypes and gene mutations. Am J Clin Pathol 128 : 100-108, 2007
 
3) Ichinokawa H, Ishii G, Nagai K, et al : Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation. Hum Pathol 44 : 2636-2642, 2013
PubMed
4) Ichinokawa H, Ishii G, Nagai K, et al : Clinicopathological characteristics of primary lung adenocarcinoma predominantly composed of goblet cells in surgically resected cases. Pathol Int 61 : 423-429, 2011
PubMed
5) Travis WD, Brambilla E, Noguchi M : International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
6) Tsuta K, Ishii G, Nitadori J, et al : Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin. J Pathol 209 : 78-87, 2006
PubMed
7) Sugano M, Nagasaka T, Sasaki E, et al : HNF4alpha as a marker for invasive mucinous adenocarcinoma of the lung. Am J Surg Pathol 37 : 211-218, 2013
PubMed
8) Yatabe Y, Koga T, Mitsudomi T, et al : CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas. J Pathol 203 : 645-652, 2004
 
9) Nakaoku T, Tsuta K, Ichikawa H, et al : Druggable oncogene fusions in invasive mucinous lung adenocarcinoma. Clin Cancer Res 20 : 3087-3093, 2014
PubMed
10) Clayton F : Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates. Cancer 57 : 1555-1564, 1986
PubMed
11) Gemma A, Noguchi M, Hirohashi S, et al : Clinicopathologic and immunohistochemical characteristics of goblet cell type adenocarcinoma of the lung. Acta Pathol Jpn 41 : 737-743, 1991
PubMed
P.83 掲載の参考文献
1) Eck H, Haupt R, Rothe G : Die gut-und bosartigen Lungengeschwulste. in Henke F, Lubarsch O (eds) : "Handbuch der speziellen pathologischen Anatomie und Histologie", Vol 11, Springer-Verlag, Berlin, 1969, pp59-61
 
2) Gao ZH, Urbanski SJ : The spectrum of pulmonary mucinous cystic neoplasia : a clinicopathologic and immunohistochemical study of ten cases and review of literature. Am J Clin Pathol 124 : 62-70, 2005
PubMed
3) Moran CA, Suster S : Tumors and Tumor-like Conditions of the Lung and Pleura. Saunders/Elsevier, Philadephia, 2010
 
4) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004
 
5) WD Travis, E Brambilla, Noguchi M : International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
6) Rossi G, Murer B, Cavazza A, et al : Primary mucinous (socalled colloid) carcinomas of the lung : a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am J Surg Pathol 28 : 442-452, 2004
 
7) Chu PG, Chung L, Weiss LM, et al : Determining the site of origin of mucinous adenocarcinoma : an immunohistochemical study of 175 cases. Am J Surg Pathol 35 : 1830-1836, 2011
PubMed
8) Achcar Rde O, Nikiforova MN, Dacic S, et al : Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. Hum Pathol 40 : 854-860, 2009
PubMed
P.91 掲載の参考文献
1) Travis WD, Brambilla E, Noguchi M, et al : International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
2) Kradin RL, Young R, Dickersin GR, et al : Pulmonary blastoma with argyrophil cells and lacking sarcomatous features (pulmonary endodermal tumor resembling fetal lung). Am J Surg Pathol 6 : 165-172, 1982
PubMed
3) Nakatani Y, Kitamura H, Inayama Y, et al : Pulmonary adenocarcinomas of the fetal lung type : a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol 22 : 399-411, 1998
PubMed
4) Koss MN, Hochholzer L, O'Leary T : Pulmonary blastomas. Cancer 67 : 2368-2381, 1991
PubMed
5) Morita S, Yoshida A, Goto A, et al : High-grade lung adenocarcinoma with fetal lung-like morphology. Clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Am J Surg Pathol 37 : 924-932, 2013
PubMed
6) 中谷行雄, 廣島健三 : 胎児型腺癌. 病理と臨床 28 : 252-258, 2010
Medical*Online
7) Nakatani Y, Dickersin GR, Mark EJ : Pulmonary endodermal tumor resembling fetal lung. A clinicopathologic study of five cases with immunohistochemical and ultrastructural characterization. Hum Pathol 21 : 1097-1107, 1990
 
8) Nakatani Y, Masudo K, Miyagi Y, et al : Aberrant nuclear localization and gene mutation of β-catenin in low-grade adenocarcinoma of fetal lung type : up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol 15 : 617-624, 2002
 
9) Yamazaki K : Pulmonary well-differentiated fetal adenocarcinoma expressing lineage-specific transcription factors (TTF-1 and GATA-6) to respiratory epithelial differentiation : an immunohistochemical and ultrastructural study. Virchows Arch 442 : 393-399, 2003
PubMed
10) Nakatani Y, Kitamura H, Inayama Y, et al : Pulmonary endodermal tumor resembling fetal lung. The optically clear nucleus is rich in biotin. Am J Surg Pathol 18 : 637-642, 1994
 
11) Wani Y, Notohara K, Nakatani Y, et al : Aberrant nuclear Cdx2 expression in morule-forming tumours in different organs, accompanied by cytoplasmic reactivity. Histopathology 55 : 465-468, 2009
PubMed
12) Sekine S, Shibata T, Matsuno Y, et al : Beta-catenin mutations in pulmonary blastomas : association with morule formation. J Pathol 200 : 214-221, 2003
PubMed
13) Proctor L, Folpe AL, Esper A, et al : Well-differentiated fetal adenocarcinoma of the lung : cytomorphologic features on fine-needle aspiration with emphasis on use of betacatenin as a useful diagnostic marker. Diagn Cytopathol 35 : 39-42, 2007
PubMed
14) Nakatani Y, Miyagi Y, Takemura T, et al : Aberrant nuclear/cytoplasmic localization and gene mutation of betacatenin in classic pulmonary blastoma : beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am J Surg Pathol 28 : 921-927, 2004
 
15) Nakatani Y, Hiroshima K, Mark EJ : Sarcomatoid carcinomas and variants. in Hasleton P, Flieder DB (eds) : "Spencer's Pathology of the Lung", 6th ed, Cambridge University Press, Cambridge, 2013, pp1186-1223
 
16) Flieder DB, Borczuk AC, Noguchi M : Adenocarcinoma of the lung. in Hasleton P, Flieder DB (eds) : "Spencer's Pathology of the Lung", 6th ed, Cambridge University Press, Cambridge, 2013, pp1043-1092
 
P.94 掲載の参考文献
1) Tsao MS, Fraser RS : Primary pulmonary adenocarcinoma with enteric differentiation. Cancer 68 : 1754-1757, 1991
PubMed
2) Yousem SA : Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study. Mod Pathol 18 : 816-821, 2005
 
3) Li HC, Schmidt L, Greenson JK et al : Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma : case report and review of literature. Am J Clin Pathol 131 : 129-133, 2009
PubMed
4) Inamura K, Satoh Y, Okumura S et al : Pulmonary adenocarcinomas with enteric differentiation : histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg Pathol 29 : 660-665, 2005
PubMed
P.99 掲載の参考文献
1) Yoshida A, Tsuta K, Nakamura H, et al : Comprehensive histologic analysis of ALK-rearranged lung carcinomas. Am J Surg Pathol 35 : 1226-1234, 2011
PubMed
2) Travis WD, Brambilla E, Noguchi M, et al : International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
3) Rodig SJ, Mino-Kenudson M, Dacic S, et al : Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res 15 : 5216-5223, 2009
PubMed
4) Jokoji R, Yamasaki T, Minami S, et al : Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma. J Clin Pathol 63 : 1066-1070, 2010
PubMed
5) Takeuchi K, Soda M, Togashi Y, et al : RET, ROS1 and ALK fusions in lung cancer. Nat Med 18 : 378-381, 2012
PubMed
6) Inamura K, Takeuchi K, Togashi Y, et al : EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol 22 : 508-515, 2009
 
7) Bergethon K, Shaw AT, Ou SH, et al : ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 30 : 863-870, 2012
PubMed
8) Yoshida A, Kohno T, Tsuta K, et al : ROS1-rearranged lung cancer : a clinicopathologic and molecular study of 15 surgical cases. Am J Surg Pathol 37 : 554-562, 2013
PubMed
9) Kohno T, Ichikawa H, Totoki Y, et al : KIF5B-RET fusions in lung adenocarcinoma. Nat Med 18 : 375-377, 2012
PubMed
10) Tsuta K, Kohno T, Yoshida A, et al : RET-rearranged nonsmall-cell lung carcinoma : a clinicopathological and molecular analysis. Br J Cancer 110 : 1571-1578, 2014
 
11) Fernandez-Cuesta L, Plenker D, Osada H, et al : CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discov 4 : 415-422, 2014
PubMed
12) Nakaoku T, Tsuta K, Ichikawa H, et al : Druggable oncogene fusions in invasive mucinous lung adenocarcinoma. Clin Cancer Res 20 : 3087-3093, 2014
PubMed
13) Vaishnavi A, Capelletti M, Le AT, et al : Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med 19 : 1469-1472, 2013
 
14) Wang R, Wang L, Li Y, et al : FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. Clin Cancer Res 20 : 4107-4114, 2014
 
15) 吉田朗彦, 蔦幸治 : 肺腺癌の組織形態への注意は融合遺伝子同定の迅速化に寄与する. 日本病理学会会誌 103 : 201, 2014
 
P.102 掲載の参考文献
1) Barbareschi M, Cantaloni C, Del Vescovo V, et al : Heterogeneity of large cell carcinoma of the lung : an immunophenotypic and miRNA-based analysis. Am J Clin Pathol 136 : 773-782, 2011
PubMed
P.105 掲載の参考文献
1) Travis WD, Colby TV, Corrin B, et al (eds) : Histological Typing of Lung and Pleural Tumours, World Health Organization International Histological Classification of Tumours, 3rd ed, Springer, Berlin, 2004
 
2) 日本肺癌学会 (編) : 肺癌取扱い規約, 第7版, 金原出版, 2010
 
3) Maeda H, Matsumura A, Kawabata T, et al : Adenosquamous carcinoma of the lung : surgical results as compared with squamous cell and adenocarcinoma cases. Eur J Cardiothorac Surg 41 : 357-361, 2012
PubMed
4) Rao N : Adenosquamous carcinoma. Semin Diagn Pathol 31 : 271-277, 2014
PubMed
5) Takamori S, Noguchi M, Morinaga S, et al : Clinicopathologic characteristics of adenosquamous carcinoma of the lung. Cancer 67 : 649-654, 1991
PubMed
6) Travis WD, Brambilla E, Noguchi M, et al : International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
7) 下里幸雄, 井内康輝 (編) : 腫瘍鑑別診断アトラス 肺, 第2版, 文光堂, 2004
 
8) Roden AC, Garcia JJ, Wehrs RN, et al : Histopathologic, immunophenotypic and cytogenetic features of pulmonary mucoepidermoid carcinoma. Mod Pathol 2014 doi : 10.1038/modpathol.2014.72
 
9) WHO Classification Lung, 2015
 
10) Bastide K, Uqolin N, Levalois C, et al : Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level? Lung Cancer 68 : 1-9, 2010
PubMed
11) Watanabe Y, Shiraishi K, Takahashi F, et al : Biomarker Expression and Druggable Gene Alterations for Development of an Appropriate Therapeutic Protocol for Pulmonary Adenosquamous Carcinoma. Histopathology 2014, doi : 10.1111/his.12556
 
12) Shiozawa T, Ishii G, Goto K, et al : Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung. Pathol Int 63 : 77-84, 2013
PubMed
13) Kanazawa H, Ebina M, Ino-Oka N, et al : Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. Am J Pathol 156 : 1289-1298, 2000
PubMed
14) Mitsudomi T, Kosaka T, Endoh H, et al : Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with nonsmall-cell lung cancer with postoperative recurrence. J Clin Oncol 23 : 2513-2520, 2005
PubMed
15) Shukuya T, Takahashi T, Kaira R, et al : Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations : a pooled analysis of published reports. Cancer Sci 102 : 1032-1037, 2011
PubMed
16) Paik PK, Varghese AM, Sima CS, et al : Response to erlotinib in patients with EGFR mutant advanced non-small cell lung cancers with a squamous or squamous-like component. Mol Cancer Ther 11 : 2535-2540, 2012
PubMed
17) Filosso PL, Ruffini E, Asioli S, et al : Adenosquamous lung carcinomas : a histologic subtype with poor prognosis. Lung Cancer 74 : 25-29, 2011
PubMed
18) Cooke DT, Nguyen DV, Yang Y, et al : Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy. Ann Thorac Surg 90 : 943-948, 2010
PubMed
P.107 掲載の参考文献
1) Nakatani Y, Hiroshima K, Mark EJ : Sarcomatoid carcinomas and variants. in Hasleton P, Flieder DB (eds) : "Spencer's Pathology of the Lung", 6th ed, Cambridge University Press, Cambridge, 2013, pp1186-1223
 
2) Thiery JP : Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2 : 442-454, 2002
PubMed
3) Holst VA, Finkelstein S, Colby TV et al : p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma : implications for histogenesis. Am J Surg Pathol 21 : 801-811, 1997
 
4) Mochizuki T, Ishii G, Nagai K et al : Pleomorphic carcinoma of the lung : clinicopathologic characteristics of 70 cases. Am J Surg Pathol 32 : 1727-1735, 2008
PubMed
5) Rossi G, Cavazza A, Sturm N et al : Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements : a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 27 : 311-324, 2003
PubMed
P.112 掲載の参考文献
1) Fishback NF, Travis WD, Moran CA, et al : Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer 73 : 2936-2945, 1994
 
2) Rossi G, Cavazza A, Sturm N, et al : Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements : a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 27 : 311-324, 2003
PubMed
3) Hasleton P : Sarcomatoid carcinoma : Pleomorphic carcinoma, spindle cell carcinoma, giant cell carcinoma, carcinosarcoma, and pulmonary blastoma. in Tomashefski JF Jr, Cagle PT, Farver CF, et al (eds) : "Dail and Hammar's Pulmonary Pathology", Springer, New York, 2008, pp375-397
 
4) Nakajima M, Kasai T, Hashimoto H, et al : Sarcomatoid carcinoma of the lung : a clinicopathologic study of 37 cases. Cancer 86 : 608-616, 1999
 
5) Pelosi G, Fraggetta F, Nappi O, et al : Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility : a clinicopathologic and immunohistochemical study of 31 cases. Am J Surg Pathol 27 : 1203-1215, 2003
PubMed
6) Nakatani Y, Hiroshima K, Mark EJ : Sarcomatoid carcinoma and variants. in Hasleton P, Flieder DB (eds) : "Spencer's Pathology of the Lung", Cambridge University Press, Cambridge, 2013, pp1186-1223
 
7) Chang YL, Lee YC, Liao WY, et al : The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer 44 : 149-157, 2004
PubMed
8) Addis BJ, Dewar A, Thurlow NP : Giant cell carcinoma of the lung- immunohistochemical and ultrastructural evidence of dedifferentiation. J Pathol 155 : 231-240, 1988
PubMed
9) Attanoos RL, Papagiannis A, Suttinont P, et al : Pulmonary giant cell carcinoma : pathological entity or morphological phenotype? Histopathology 32 : 225-231, 1998
PubMed
10) Holst VA, Finkelstein S, Colby TV, et al : p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma : implications for histogenesis. Am J Surg Pathol 21 : 801-811, 1997
 
11) Przygodzki RM, Koss MN, Moran CA, et al : Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by Kras-2 and p53 analysis. Am J Clin Pathol 106 : 487-492, 1996
 
12) Pelosi G, Scarpa A, Manzotti M, et al : K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol 17 : 538-546, 2004
PubMed
13) Chang YL, Wu CT, Shih JY, et al : EGFR and p53 status of pulmonar y pleomorphic carcinoma : implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy. Ann Surg Oncol 18 : 2952-2960, 2011
 
14) Ushiki A, Koizumi T, Kobayashi N, et al : Genetic heterogeneity of EGFR mutation in pleomorphic carcinoma of the lung : response to gefitinib and clinical outcome. Jpn J Clin Oncol 39 : 267-270, 2009
PubMed
15) Przygodzki RM, Koss MN, O'Leary TJ : Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12. Mol Diagn 6 : 109-115, 2001
PubMed
P.115 掲載の参考文献
1) Nakatani Y, Hiroshima K, Mark EJ : Sarcomatoid carcinomas and variants. in Hasleton P, Flieder DB (eds) : "Spencer's Pathology of the Lung", 6th ed, Cambridge University Press, Cambridge, 2013, pp1186-1223
 
2) Koss MN, Hochholzer L, Frommelt RA : Carcinosarcomas of the lung : a clinicopathologic study of 66 patients. Am J Surg Pathol 23 : 1514-1526, 1999
 
3) Nakatani Y, Miyagi Y, Takemura T, et al : Aberrant nuclear/cytoplasmic localization and gene mutation of betacatenin in classic pulmonar y blastoma : beta-catenin immuno staining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am J Surg Pathol 28 : 921-927, 2004
 
4) Morita S, Yoshida A, Goto A, et al : High-grade lung adenocarcinoma with fetal lung-like morphology. Clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Am J Surg Pathol 37 : 924-932, 2013
PubMed
5) Holst VA, Finkelstein S, Colby TV, et al : p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma : implications for histogenesis. Am J Surg Pathol 21 : 801-811, 1997
 
6) Toyokawa G, Takenoyama M, Taguchi K, et al : The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene. Lung Cancer 81 : 491-494, 2013
PubMed
P.118 掲載の参考文献
1) Spencer H : Pulmonary blastomas. Journal of Pathology and Bacteriology 82 : 161-165, 1961
 
2) Koss MN, Hochholzer L, O'Leary T : Pulmonary blastomas. Cancer 67 : 2368-2381, 1991
PubMed
3) Nakatani Y, Hiroshima K, Mark EJ : Sarcomatoid carcinomas and variants. in Hasleton P, Flieder DB (eds) : "Spencer's Pathology of the Lung", 6th ed, Cambridge University Press, Cambridge, 2013, pp1186-1223
 
4) Francis D, Jacobsen M : Pulmonary blastoma. Curr Top Pathol 73 : 265-294, 1983
PubMed
5) Sekine S, Shibata T, Matsuno Y, et al : Beta-catenin mutations in pulmonary blastomas : association with morule formation. J Pathol 200 : 214-221, 2003
PubMed
6) Nakatani Y, Miyagi Y, Takemura T, et al : Aberrant nuclear/cytoplasmic localization and gene mutation of betacatenin in classic pulmonary blastoma : beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am J Surg Pathol 28 : 921-927, 2004
 
P.132 掲載の参考文献
1) 日本肺癌学会 (編) : 肺癌取扱い規約, 第7版, 金原出版, 2010
 
2) Klimstra DS, Modlin IR, Adsay NV, et al : Pathology reporting of neuroendocrine tumors : application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg 34 : 300-313, 2010
 
3) Kloppel G, Rindi G, Perren A, et al : The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas : a statement. Virchows Arch 456 : 595-597, 2010
PubMed
4) Travis WD, Brambilla E, Muller-Hermelink K, et al (eds) : WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, IARC Press, Lyon, 2004
 
5) Rekhtman N : Neuroendocrine tumors of the lung : an update. Arch Pathol Lab Med 134 : 1628-1638, 2010
PubMed
6) Volante M, Brizzi MP, Faggiano A, et al : Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors : a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20 : 1172-1182, 2007
PubMed
7) Bertino EM, Confer PD, Colonna JE, et al : Pulmonary neuroendocrine/carcinoid tumors : a review article. Cancer 115 : 4434-4441, 2009
PubMed
8) Grozinsky-Glasberg S, Pavel M : Inhibition of mTOR in carcinoid tumors. Target Oncol 7 : 189-195, 2012
PubMed
9) Corrin B : Carcinoid tumours and tumourlets. in "Pathology of the Lungs", Churchill Livingstone, London, 2000, pp505-513
 
10) Tsuta K, Kalhor N, Wistuba II, et al : Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung. Histopathology 59 : 526-536, 2011
PubMed
11) Hasleton P, Flieder DB (eds) : Spencer's Pathology of the Lung, 6th ed, Cambridge University Press, Cambridge, 2013, pp1172-1177
 
12) Tomashefski JF (ed) : Dail and Hammer's Pulmonary Pathology, 3rd ed, Springer, New York, 2008, pp197-201, 314-315
 
13) Ullmann R, Petzmann S, Klemen H, et al : The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues. Genes Chromosomes Cancer 34 : 78-85, 2002
PubMed
14) Jones MH, Virtanen C, Honjoh D, et al : Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 363 : 775-781, 2004
PubMed
P.139 掲載の参考文献
1) Travis WD, Colby TV, Corrin B, et al (eds) : WHO International Histological Classification of Tumors : Histological Typing of Lung and Pleural Tumors. 3rd ed, Springer-Verlag, Berlin 1999
 
2) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours : Pathology and Genetics of the Lung, Pleura, Thymus, and Hear t Tumours. IAPC Press, Lyon, 2004
 
3) Barnes L, Eveson JW, Reichart P, et al (eds) : WHO Classification of Tumors : Pathology and Genetics of the Head and Neck Tumors. IAPC Press, Lyon, 2005
 
P.140 掲載の参考文献
1) Chang YL1, Wu CT, Shih JY, et al : Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas. Cancer Sci 102 : 282-287, 2011
 
2) Liang Y, Wang L, Zhu Y, et al : Primary pulmonary lymphoepithelioma-like carcinoma : fifty-two patients with longterm follow-up. Cancer 118 : 4748-4758, 2012
PubMed
3) French CA, Kutok JL, Faquin WC, et al : Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22 : 4135-4139, 2004
 
4) Tanaka M, Kato K, Gomi K, et al : NUT midline carcinoma : report of 2 cases suggestive of pulmonary origin. Am J Surg Pathol 36 : 381-388, 2012
PubMed
5) Stelow EB, Bellizzi AM, Taneja K, et al : NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol 32 : 828-834, 2008
PubMed
P.153 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours. Pathology and Genetics. Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) England DM, Hochholzer L, McCarthy MJ : Localized benign and malignant fibrous tumors of the pleura : a clinicopathologic review of 223 cases. Am J Surg Pathol 13 : 640-658, 1989
PubMed
3) Goldblum JR, Folpe AL, Weiss SW : Enzinger and Weiss's Soft Tissue Tumors, 6th ed, Mosby, St Louis, 2008
 
4) Ordonez NG : Localized (solitary) fibrous tumor of the pleura. Avd Anat Pathol 7 : 327-340, 2000
 
5) Cavazza A, Rossi G, Agostini L, et al : Cytokeratin-positive malignant solitary fibrous tumor of the pleura : an unusual pitfall in the diagnosis of pleural spindle cell neoplasms. Histopathology 43 : 606-608, 2003
 
6) Dail D, Liebow A : Intravascular bronchioloalveolar tumor. Am J Pathol 78 : 6a-7a, 1975
 
7) Weiss SW, Enzinger FM : Epithelioid hemangioendothelioma : a vascular tumor often mistaken for a carcinoma. Cancer 50 : 970-981, 1982
PubMed
8) Fletcher CD, Unni K, Mertens F (eds) : World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, IARC Press, Lyon, 2002
 
9) Amin RM, Hiroshima K, Kokubo T, et al : Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report. Respirology 11 : 818-825, 2006
 
10) Lau K, Massad M, Pollak C, et al : Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement : insights from an internet registry in the study of a rare cancer. Chest 140 : 1312-1318, 2011
PubMed
11) Manivel JC, Priest JR, Watterson J, et al : Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood. Cancer 62 : 1516-1526, 1988
PubMed
12) The International Pleuropulmonary Blastoma Registry. Available at : http://www.ppbregistry.org
 
13) 田中祐吉, 田中水緒, 五味淳 : 胸膜肺芽腫. 病理と臨床 28 : 282-287, 2010
Medical*Online
14) Priest JR, McDermott MB, Bhatia S, et al : Pleuropulmonary blastoma : a clinicopathologic study of 50 cases. Cancer 80 : 147-161, 1997
PubMed
15) Lndolft P, Bisogno G, Casale F, et al : Prognostic factors in pleuro-pulmonary blastoma. Pediatr Blood Cancer 48 : 318-323, 2007
PubMed
16) Hill DA, Ivanovich J, Priest JR, et al : DICER1 mutations in familial pleuropulmonary blastoma. Science 325 : 965, 2009
PubMed
17) McGinnis M, Jacobs G, el-Naggar A, et al : Congenital peribronchial myofibroblastic tumor (so-called "congenital leiomyosarcoma"). A distinct neonatal lung lesion associated with nonimmune hydrops fetalis. Mod Pathol 6 : 487-492, 1993
PubMed
18) Huppmann AR, Coffin CM, Hoot AC, et al : Congenital peribronchial myofibroblastic tumor : comparison of fetal and postnatal morphology. Pediatr Dev Pathol 14 : 124-129, 2011
PubMed
19) Kim Y, Park HY, Cho J, et al : Congenital peribronchial myofibroblastic tumor : a case study and literature review. Korean J Pathol 47 : 172-176, 2013
PubMed
20) Chang C, Hung LY, Thanh TT, et al : Congenital peribronchial myofibroblastic tumour with features of maturation in the older infant : report of two cases with a literature review. Histopathology 64 : 755-757, 2014
 
21) Carney JA, Sheps SG, Go VL, et al : The triad of gastric leiomyosarcoma, functioning extraadrenal paraganglioma and pulmonary chondroma. N Engl J Med 296 : 1517-1518, 1977
PubMed
22) Rodriguez FJ, Aubry MC, Tazelaar HD, et al : Pulmonary chondroma : a tumor associated with Carney triad and different from pulmonary hamartoma. Am J Surg Pathol 31 : 1844-1853, 2007
PubMed
23) 坪井光弘, 吉澤潔, 環正文他 : 不完全型Carney's triadの1例-本邦報告11例の臨床的検討. 日本呼吸器外科学会雑誌 26 : 79-84, 2012
 
24) Fetsch JF, Montgomery EA, Meis JM : Calcifying fibrous pseudotumor. Am J Surg Pathol 17 : 502-508, 1993
PubMed
25) Pinkard NB, Wilson RW, Lawless N, et al : Calcifying fibrous pseudotumor of pleura : a report of three cases of a newly described entity involving the pleura. Am J Clin Pathol 105 : 189-194, 1996
PubMed
26) Kawahara K, Yasukawa M, Nakagawa K, et al : Multiple calcifying fibrous tumor of the pleura. Virchows Arch 447 : 1007-1008, 2005
PubMed
27) Ishida M, Okabe H : Disseminated calcifying tumor of the pleura. Pathol Int 3 : 333-335, 2013
 
28) Faul JL, Berry GJ, Colby TV, et al : Thoracic lymphangiomatosis, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med 161 : 1037-1046, 2000
PubMed
29) Boland JM, Tazelaar HD, Colby TV, et al : Diffuse pulmonary lymphatic disease presenting as interstitial lung disease in adulthood : report of 3 cases. Am J Surg Pathol 36 : 1548-1554, 2012
PubMed
30) Takahashi K, Takahashi H, Maeda K, et al : An adult case of lymphangiomatosis of the mediastinum, pulmonary interstitium and retroperitoneum complicated by chronic disseminated intravascular coagulation. Eur Respir J 8 : 1799-1802, 1995
PubMed
31) Muramatsu T, Shimamura M, Furuichi M, et al : Desmoplastic small round cell tumor of the lung. Ann Thorac Surg 90 : 86-87, 2010
 
32) Wang Z, Xiao W, Zheng S : Desmoplastic small round cell tumor of the lung : case report. Chin Med J 120 : 2327-2328, 2007
 
33) Nishant R, Mradul KD, Nitin S, et al : A rapidly developing lung mass diagnosed as desmoplastic small round cell tumor. Lung India 28 : 287-290, 2011
 
34) Lae ME, Roche PC, Jin L, et al : Desmoplastic small round cell tumor : a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 26 : 823-835, 2002
PubMed
P.165 掲載の参考文献
1) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, IARC Press, Lyon, 2004, pp113-121
 
2) Colby TV, Koss MN, Travis WD : Tumors of the Lower Respiratory Tract. Atlas of Tumor Pathology, 3rd series, American Registry of Pathology, Washington, DC, 1995, pp465-494
 
3) Muraoka M, Oka T, Akamine S, et al : Endobronchial lipoma : review of 64 cases reported in Japan. Chest 123 : 293-296, 2003
PubMed
4) Keylock JB, Galvin JR, Franks TJ : Sclerosing hemangioma of the lung. Arch Pathol Lab Med 133 : 820-825, 2009
PubMed
5) Martignoni G, Pea M, Reghellin D, et al : PEComas : the past, the present and the future. Virchows Arch 452 : 119-132, 2008
PubMed
6) Hironaka M, Fukayama M : Regional proliferation of HMB-45-positive clear cells of the lung with lymphangioleiomyomatosis-like distribution, replacing the lobes with multiple cysts and a nodule. Am J Surg Pathol 23 : 1288-1293, 1999
 
7) Kenerson H, Folpe AL, Takayama TK, et al : Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol 38 : 1361-1371, 2007
PubMed
8) Malinowska I, Kwiatkowski DJ, Weiss S, et al : Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas : further evidence for a biological distinction. Am J Surg Pathol 36 : 783-784, 2012
PubMed
9) Doyle LA, Hornick JL, Fletcher CD : PEComa of the gastrointestinal tract : clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol 37 : 1769-1782, 2013
PubMed
10) Muir TE, Leslie KO, Popper H, et al : Micronodular pneumocyte hyperplasia. Am J Surg Pathol 22 : 465-472, 1998
PubMed
11) Kobashi Y, Sugiu T, Mouri K, et al : Clinicopathological analysis of multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis in Japan. Respirology 13 : 1076-1081, 2008
PubMed
12) Hayashi T, Kumasaka T, Mitani K, et al : Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia. Mod Pathol 23 : 1251-1260, 2010
PubMed
P.170 掲載の参考文献
1) Liebow AA, Currington CB : The interstitial pneumonia. in Simon M, Potchen EJ, LeMay M (eds) : "Frontiers of Pulmonary Radiology : Patholophysiologic, Roentogenographic and Redioisotopic Consideration : Proceedings of the Symposium Sponsored by Harvard Medical School", Grune & Stratton, New York, 1967, pp102-141
 
2) Cha S-I, Fessler MB, Cool CD, et al : Lymphoid interstitial pneumonia : clinical features, associations and prognosis. Eur Respir J 28 : 364-369, 2006
PubMed
3) Guinee DG Jr, Franks TJ, Gerbino AJ, et al : Pulmonary nodular lymphoid hyperplasia (pulmonary pseudolymphoma) : the significance of increased numbers of IgG4-positive plasma cells. Am J Surg Pathol 37 : 699-709, 2013
PubMed
4) Troch M, Kiesewetter B, Raderer M : Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma. Curr Hematol Malig Rep 6 : 216-221, 2011
PubMed
5) Kurtin PJ, Myers JL, Adlakha H, et al : Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol 25 : 997-1008, 2001
PubMed
6) Naresh KN, Barwick T, Karadimitris A : IgG4 positive mucosa associated lymphoid tissue lymphoma of the orbitlesson of the month. Histopathology 2014, 12 [Epub ahead of print]
 
7) Farinha P, Gascoyne RD : Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 23 : 6370-6378, 2005
PubMed
8) Karin M : Nuclear factor-kappaB in cancer development and progression. Nature 441 : 431-436, 2006
PubMed
P.173 掲載の参考文献
1) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, IARC Press, Lyon, 2004
 
2) Cadranel J, Wislez M, Antoine M : Primary pulmonary lymphoma. Eur Respir J 20 : 750-762, 2002
PubMed
3) Neri N, Jesus Nambo M, Aviles A : Diffuse large B-cell lymphoma primary of lung. Hematology 16 : 110-112, 2011
PubMed
4) Murase T, Yamaguchi M, Suzuki R, et al : Intravascular large B-cell lymphoma (IVLBCL) : a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109 : 478-485, 2007
 
5) Ray P, Antoine M, Mary-Krause M, et al : AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med 158 : 1221-1229, 1998
PubMed
6) Chen G, Yim AP, Ma L, et al : Primary pulmonary large B-cell lymphoma-mediastinal type? Histopathology 58 : 324-326, 2011
 
P.177 掲載の参考文献
1) Liebow AA, Carrington CR, Friedman PJ : Lymphomatoid granulomatosis. Hum Pathol 3 : 457-558, 1972.
PubMed
2) Pittaluga S, Wilson WH, Jaffe ES : Lymphomatoid granulomatosis. in Swerdlow SH, Campo E, Harris NL, et al (eds) : "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue", 4th ed, IARC Press, Lyon, 2008, pp247-249
 
3) Roschewski M, Wilson WH : Lymphomatoid granulomatosis. Cancer J 18 : 469-474, 2012
PubMed
4) Guinee D Jr, Jaffe E, Kingma D, et al : Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 18 : 753-764, 1994.
PubMed
5) Katzenstein AL, Doxtader E, Narendra S : Lymphomatoid granulomatosis : insights gained over 4 decades. Am J Surg Pathol 34 : e35-48, 2010
PubMed
6) Koss MN, Harris NL : Lymphomatoid granulomatosis. in Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : "WHO Classification of Tumours of Lung, Pleura and Mediastinum", IARC Press, Lyon, 2004, pp92-94
 
P.181 掲載の参考文献
1) Deshpande V, Zen Y, Chan JK, et al : Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25 : 1181-1192, 2012
PubMed
2) Hamano H, Kawa S, Horiuchi A, et al : High serum IgG4 concentrations inpatients with sclerosing pancreatitis. N Engl J Med 8 : 732-738, 2001
 
3) Taniguchi T, Ko M, Seko S, et al : Interstitial pneumonia associated with autoimmune pancreatitis. Gut 53 : 770-771, 2004
PubMed
4) Zen Y, Inoue D, Kitao A, et al : IgG4-related lung and pleural disease : a clinicopathologic study of 21 cases. Am J Surg Pathol 33 : 1886-1893, 2009
PubMed
5) Hamano H, Arakura N, Muraki T, et al : Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 41 : 1197-1205, 2006
PubMed
6) Umehara H, Okazaki K, Masaki Y, et al : Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22 : 21-30, 2012
PubMed
7) Inoue D, Zen Y, Abo H,et al : Immunoglobulin G4-related lung disease : CT findings with pathologic correlations. Radiology 251 : 260-270, 2009
PubMed
8) Hirano K, Kawabe T, Komatsu Y, et al : High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J 36 : 58-61, 2006
PubMed
9) Deshpande V, Chicano S, Finkelberg D, et al : Autoimmune pancreatitis : a systemic immune complex mediated disease. Am J Surg Pathol 30 : 1537-1545, 2006
PubMed
10) Ogoshi T, Kido T, Yatera K, et al : Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease. Lung 191 : 575-583, 2013
PubMed
11) Yamamoto M, Takahashi H, Suzuki C, et al : Analysis of serum IgG subclasses in Churg-Strauss syndrome-the meaning of elevated serum levels of IgG4. Intern Med 49 : 1365-1370, 2010
PubMed
12) Takeuchi M, Sato Y, Ohno K, et al : T helper 2 and regulatory T-cell cytokine production by mast cells : a key factor in the pathogenesis of IgG4-related disease. Mod Pathol 27 : 1126-1136, 2014
PubMed
P.188 掲載の参考文献
1) Jagirdar J : Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med 132 : 384-396, 2008
 
2) Tot T : Cytokeratins 20 and 7 as biomarkers : usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 38 : 758-763, 2002
PubMed
3) Park SY : Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med 131 : 1561-1567, 2007
PubMed
4) Dennis JL : Markers of adenocarcinoma characteristic of the site of origin : development of a diagnostic algorithm. Clin Cancer Res 11 : 3766-3772, 2005
PubMed
5) Afify AM, al-Khafaji BM : Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Acta Cytol 46 : 675-678, 2002
PubMed
6) Jan IS, Chung PF, Weng MH, et al : Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique. J Formos Med Assoc 105 : 695-700, 2006
PubMed
7) Chhieng DC, Cangiarella JF, Zakowski MF, et al : Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer 93 : 330-336, 2001
PubMed
8) Bishop JA, Sharma R, Illei PB : Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol 41 : 20-25, 2010
PubMed
9) Laury AR, Perets R, Piao H, et al : A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol 35 : 816-826, 2011
PubMed
10) Malin RD, Ionita E, Osman I, et al : Histopathological and immunohistochemical study of laterocervical lymph node metastases of unknown primary origin. Rom J Morphol Embryol 53 : 337-342, 2012
PubMed
11) 坂口幸治, 山本学, 堀尾裕俊 : 胃癌術後の孤立性肺転移切除例の検討. 肺癌 47 : 323-326, 2007
Medical*Online
12) 大腸癌研究会 (編) : 大腸癌治療ガイドライン, 2013 (http://www.jsco-cpg.jp/item/13/)
 
13) Travis WD, Brambilla E, Noguchi M, et al : International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
14) 亀岡信悟, 大貫恭正, 山口直人 : 大腸癌研究会 肝転移プロジェクト研究報告, 2010 (http://jsccr.jp/project/pdf/slide05.pdf)
 
15) 西野佳浩, 広橋一裕, 首藤太一 他 : 肝細胞癌切除後肺転移例に対する肺切除の意義と適応. 日本消化器外科学会雑誌 33 : 1468-1472, 2000
 
16) 山口豊 : 消化器癌の肺転移に対する外科治療. 日本消化器外科学会雑誌 21 : 2205-2209, 1988
 
17) 高野可赴, 黒崎功, 皆川昌広他 : 膵癌切除例における遅発性孤立性肺転移の臨床病理組織学的特徴と化学療法の意義. 日本消化器外科学会雑誌 43 : 1270-1275, 2010
 
18) Ordonez NG : Napsin A expression in lung and kidney neoplasia : a review and update. Adv Anat Pathol 19 : 66-73, 2012
 
19) Minuti G, D'Incecco A, Cappuzzo F : Targeted therapy for NSCLC with driver mutations. Expert Opin Biol Ther 13 : 1401-1412, 2013
PubMed
20) Martini N, Melamed MR : Multiple primary lung cancers. J Thorac Cardiovasc Surg 70 : 606-611, 1975
PubMed
P.209 掲載の参考文献
1) Koo CW, Baliff JP, Torigian DA, et al : Spectrum of pulmonary neuroendocrine cell proliferation : diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids. AJR Am J Roentgenol 195 : 661-668, 2010
PubMed
2) Gosney JR, Williams IJ, Dodson AR, et al : Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Histopathology 59 : 751-762, 2011
PubMed
3) Niho S, Yokose T, Nishiwaki Y, et al : Immunohistochemical and clonal analysis of minute pulmonary meningothelial-like nodules. Hum Pathol 30 : 425-429, 1999
PubMed
4) Mukhopadhyay S, El-Zammar OA, Katzenstein AL : Pulmonary meningothelial-like nodules : new insights into a common but poorly understood entity. Am J Surg Pathol 33 : 487-495, 2009
PubMed
5) Mizutani E, Tsuta K, Maeshima AM, et al : Minute pulmonary meningothelial-like nodules : clinicopathologic analysis of 121 patients. Hum Pathol 40 : 678-682, 2009
PubMed
6) Maruyama H, Ohbayashi C, Hino O, et al : Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2. Pathol Int 51 : 585-594, 2001
PubMed
7) Kobashi Y, Sugiu T, Mouri K, et al : Clinicopathological analysis of multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis in Japan. Respirology 13 : 1076-1081, 2008
PubMed
8) Arber DA, Weiss LM, Chang KL : Detection of Epstein-Barr virus in inflammatory pseudotumor. Semin Diagn Pathol 15 : 155-160, 1998
PubMed
9) Gravdahl DJ, Gardetto JS, Hurley JR, et al : Pulmonary histoplasmosis producing a spindle cell "pseudotumor". Am J Clin Pathol 136 : 410-415, 2011
PubMed
10) Philip J, Beasley MB, Dua S : Mycobacterial spindle cell pseudotumor of the lung. Chest 142 : 783-784, 2012
PubMed
11) Cook JR, Dehner LP, Collins MH, et al : Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor : a comparative immunohistochemical study. Am J Surg Pathol 25 : 1364-1371, 2001
PubMed
12) Zen Y, Kitagawa S, Minato H, et al : IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 36 : 710-717, 2005
PubMed
13) Hartman GE, Shochat SJ : Primary pulmonary neoplasms of childhood : a review. Ann Thorac Surg 36 : 108-119, 1983
PubMed
14) Matsubara O, Tan-Liu NS, Kenney RM, et al : Inflammatory pseudotumors of the lung : progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granuloma in 32 cases. Hum Pathol 19 : 807-814, 1988
PubMed
15) Travis WD : Non-Neoplastic Disorders of the Lower Respiratory Tract (Atlas of Nontumor Pathology), ARP Press, Silver Spring, 2002
 
16) Yousem SA, Hochholzer L : Malignant fibrous histiocytoma of the lung. Cancer 60 : 2532-2541, 1987
PubMed
17) Bhagat P, Bal A, Das A, et al : Pulmonary inflammatory myofibroblastic tumor and IgG4-related inflammatory pseudotumor : a diagnostic dilemma. Virchows Arch 463 : 743-747, 2013
PubMed
18) Takeuchi K, Soda M, Togashi Y, et al : Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK : reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Clin Cancer Res 17 : 3341-3348, 2011
PubMed
19) Chapman EM, Gown A, Mazziotta R, et al : Pulmonary hyalinizing granuloma with associated elevation in serum and tissue IgG4 occurring in a patient with a history of sarcoidosis. Am J Surg Pathol 36 : 774-778, 2012
 
20) Yousem SA, Hochholzer L : Pulmonary hyalinizing granuloma. Am J Clin Pathol 87 : 1-6, 1987
PubMed
21) 森田幹太, 小泉宏隆, 高桑俊文 : PCR法を用いたホルマリン固定パラフィン包埋材料からの結核菌DNAの検出. 病理と臨床 15 : 433-437, 1997
Medical*Online
22) 堤寛 : 病理業務と結核感染. 病理と臨床 15 : 442-445, 1997
Medical*Online
23) 堤寛 : 輸入真菌症 I : ブラストミセス症, コクシジオイデス症, パラコクシジオイデス症. 感染症病理アトラス, 文光堂, 東京, 2000
 
24) 堤寛 : フィラリア症, オンコセルカ症, 犬糸状虫症. 感染症病理アトラス, 文光堂, 東京, 2000
 
25) Badalian-Very G, Vergilio JA, Degar BA, et al : Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116 : 1919-1923, 2010
PubMed
26) Sahm F, Capper D, Preusser M, et al : BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood 120 : e28-34, 2012
PubMed
27) Clarke BE : Cystic lung disease. J Clin Pathol 66 : 904-908, 2013
PubMed
28) Sato T, Seyama K, Fujii H, et al : Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 47 : 20-28, 2002
PubMed
29) McCormack FX, Inoue Y, Moss J, et al : Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364 : 1595-1606, 2011
PubMed
30) Bonetti F, Chiodera PL, Pea M, et al : Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol 17 : 1092-1102, 1993
PubMed
31) Kijner CH, Yousem SA : Systemic light chain deposition disease presenting as multiple pulmonary nodules. A case report and review of the literature. Am J Surg Pathol 12 : 405-413, 1988
PubMed
32) Channabasavaiah AD, Joseph JV : Thoracic endometriosis : revisiting the association between clinical presentation and thoracic pathology based on thoracoscopic findings in 110 patients. Medicine (Baltimore) 89 : 183-188, 2010
PubMed
33) Alifano M, Trisolini R, Cancellieri A, et al : Thoracic endometriosis : current knowledge. Ann Thorac Surg 81 : 761-769, 2006
PubMed
34) Tandon M, Warnock ML : Plexogenic angiopathy in pulmonary intralobar sequestrations : pathogenetic mechanisms. Hum Pathol 24 : 263-273, 1993
PubMed
35) Pick A, Deschamps C, Stanson AW : Pulmonary arteriovenous fistula : presentation, diagnosis, and treatment. World J Surg 23 : 1118-1122, 1999
PubMed

第3部 鑑別ポイント

P.216 掲載の参考文献
1) Rossi G, Graziano P, Leone A, et al : The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas. Semin Diagn Pathol 30 : 298-312, 2013
PubMed
2) Sandler A, Gray R, Perry MC, et al : Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355 : 2542-2550, 2006
PubMed
3) Scagliotti GV, Parikh P, von Pawel J, et al : Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26 : 3543-3551, 2008
PubMed
4) 中谷行雄, 太田聡 : p40 (ΔNp63) : p63に代わる肺扁平上皮癌マーカー. 病理と臨床 30 : 462-464, 2012
Medical*Online
P.223 掲載の参考文献
1) 蔦幸治, 横瀬智之, 石井源一郎他 : 術中迅速病理診断における肺癌の線維化巣評価の工夫. 病理と臨床 22 : 91-94, 2004
Medical*Online
2) Mizutani E, Tsuta K, Maeshima AM, et al : Minute pulmonary meningothelial-like nodules : clinicopathologic analysis of 121 patients. Hum Pathol 40 : 678-682, 2009
PubMed
3) Nitadori J, Bograd AJ, Kadota K, et al : Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. J Natl Cancer Inst 105 : 1212-1220, 2013
PubMed
4) Arai Y, Shimizu S, Eimoto T, et al : Peripheral pulmonary papillary/glandular neoplasms with ciliated cells and a component of well-differentiated adenocarcinoma : report of three tumours. Histopathology 56 : 265-269, 2010
 
5) Aida S, Ohara I, Shimazaki H, et al : Solitary peripheral ciliated glandular papillomas of the lung : a report of 3 cases. Am J Surg Pathol 32 : 1489-1494, 2008
 
6) Fugo K, Matsuno Y, Okamoto K, et al : Solitary capillary hemangioma of the lung : report of 2 resected cases detected by high-resolution CT. Am J Surg Pathol 30 : 750-753, 2006
PubMed
7) Shiono S, Ishii G, Nagai K, et al : Predictive factors for local recurrence of resected colorectal lung metastases. Ann Thorac Surg 80 : 1040-1045, 2005
PubMed
8) Copeland JN, Amin MB, Humphrey PA, et al : The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung : special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol 117 : 552-557, 2002
 
9) 菅野優, 蔦幸治, 澁木康雄他 : 術中迅速細胞診を中心としたワークフローによる肺切除標本からの空気感染防止対策の紹介. 都臨技会誌 41 : 27-32, 2013
 
P.228 掲載の参考文献
1) Travis, WD, Brambilla E, Noguchi M, et al : The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 6 : 244-285, 2011
 
2) 石川雄一 : 浸潤性腺癌-新分類における意味とその問題点. 病理と臨床 30 : 492-496, 2012
Medical*Online
3) Noguchi M, Morikawa A, Kawasaki M, et al : Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 : 2844-2852, 1995
PubMed
4) Borczuk AC, Qian F, Kazeros A, et al : Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol 33 : 462-469, 2009
PubMed
5) Matsubara D, Morikawa T, Goto A, et al : Subepithelial myofibroblast in lung adenocarcinoma : a histological indicator of excellent prognosis. Mod Pathol 22 : 776-785, 2009
PubMed
6) Rena O, Papalia E, Ruffini E, et al : Stage I pure bronchioloalveolar carcinoma : recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg 23 : 409-414, 2003
 
7) Yim J, Zhu LC, Chiriboga L, et al : Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol 20 : 233-241, 2007
PubMed
8) Kato F, Hamasaki M, Miyake Y, et al : Clinicopathological characteristics of subsentimeter adenocarcinomas of the lung. Lung Cancer 77 : 495-500, 2012
PubMed
9) Hamasaki M, Kato F, Koga K, et al : Invasion of the inner and outer layers of the visceral pleura in pT1 size lung adenocarcinoma measuring < 3cm : correlation with malignant aggressiveness and prognosis. Virchows Arch 461 : 513-519, 2012
 
P.232 掲載の参考文献
1) Nagaishi C : Pulmonary pleura. in Nagaishi C, Nagasawa N, Yamashita M, et al (eds) : "Functional Anatomy and Histology of the Lung", University Park Press, Baltimore, 1972, pp254-270
 
2) Tomashefsky JF, Faver CF : Anatomy and histology of the lung. in Tomashefsky JF, Cagle PT, Faver CF, et al (eds) : "Dail and Hammar's Pulmonar y Pathology", 3rd ed, Springer, New York, 2008, pp20-48
 
3) Pleura and chest wall. in Corrin B, Nicholson AG (eds) : "Pathology of the Lungs", 3rd ed, Churchill Livingstone, Edinburgh, 2011, pp707-752
 
4) Travis WD, Brambilla E, Rami-Porta R, et al : Visceral pleural invasion. Pathologic criteria and use of elastic stains. Proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 3 : 1384-1390, 2008
PubMed
5) Goldstraw P : Staging Manual in Thoracic Oncology. Editorial Rx Press, Orange Park, 2009, pp1-163
 
6) 正岡昭, 藤井義敬 : 呼吸器外科学, 改訂第3版, 南山堂, 2003, pp147, 342
 
7) Lung and pleural tumours. in Sobin LH, Gospodarowicz MK, Wittekind C (eds) : "UICC International Union Against Cancer, TNM Classification of Malignant Tumours", 7th ed, Wiley-Blackwell, West Sussex, 2010, pp136-150
 
8) Explanatory notes for anatomic sites-lung. in Wittekind C, Greene FL, Henson DE, et al (eds) : "UICC International Union Against Cancer, TNM Supplement, A Commentary on Uniform Use", 3rd ed, Wiley-Liss, New York, 2003, pp47-49
 
P.238 掲載の参考文献
1) Okasaka T, Usami N, Mitsudomi T, et al : Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy. J Surg Oncol 98 : 510-514, 2008
PubMed
2) Radzikowska E, Langfort R, Giedronowicz D : Estrogen and progesterone receptors in non small cell lung cancer patients. Ann Thorac Cardiovasc Surg 8 : 69-73, 2002
PubMed
3) Sasaki E, Tsunoda N, Hatanaka Y, et al : Breast-specific expression of MGB1/mammaglobin : an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers. Mod Pathol 20 : 208-214, 2007
PubMed
4) Sakamoto H, Shimizu J, Horio Y, et al : Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol 212 : 287-294, 2007
PubMed
5) Krasinskas AM, Chiosea SI, Pal T, et al : KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas. Mod Pathol 27 : 262-270, 2014
PubMed
6) Ordonez NG : Value of PAX 8 immunostaining in tumor diagnosis : a review and update. Adv Anat Pathol 19 : 140-151, 2012
 
7) Weissferdt A, Moran CA : Pax8 expression in thymic epithelial neoplasms : an immunohistochemical analysis. Am J Surg Pathol 35 : 1305-1310, 2011
PubMed

第4部 臨床との連携

P.250 掲載の参考文献
1) Henschke CI, Yankelevitz DF, Mirtcheva R, et al : CT screening for lung cancer : frequency and significance of part-solid and nonsolid nodules. AJR 178 : 1053-1057, 2002
PubMed
2) 日本CT検診学会肺がん診断基準部会 (編) : 低線量CTによる肺がん検診の肺結節の判定基準と経過観察の考え方, 第3版, 2013年5月追加改訂 (http://www.jscts.org/index.php?page=guideline_index, 2013年12月23日確認)
 
3) Naidich DP, Bankier AA, MacMahon H, et al : Recommendations for the management of subsolid pulmonary nodules detected at CT : a statement from the Fleischner Society. Radiology 266 : 304-317, 2013
PubMed
4) Travis WD, Brambilla E, Noguchi M, et al : International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
P.256 掲載の参考文献
1) http://www.haigan.gr.jp/uploads/photos/872.pdf
 
2) 日本肺癌学会 (編) : 肺癌取扱い規約. 第7版, 金原出版, 2010
 
3) 村岡昌司, 赤嶺晋治, 土谷智史他 : 術前未確定診断の肺腫瘤性病変に対する術中吸引針生検の有用性と安全性に関する検討. 日本呼吸器外科学会雑誌 20 : 700-705, 2006
 
4) Satoh Y, Hoshi R, Ishikawa Y, et al : Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology. Ann Thorac Surg 83 : 197-202, 2007
PubMed
5) Saso S, Rao C, Ashrafian H, et al : Positive pre-resection pleural lavage cytology is associated with increased risk of lung cancer recurrence in patients undergoing surgical resection : a meta-analysis of 4450 patients. Thorax 67 : 526-532, 2012
PubMed
6) Feller-Kopman D, Yung RC, Burroughs F, et al : Cytology of endobronchial ultrasound-guided transbronchial needle aspiration : a retrospective study with histology correlation. Cancer 117 : 482-490, 2009
PubMed
7) Kakinuma H, Mikami T, Iwabuchi K, et al : Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas. Comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas. Cancer Cytopathol 99 : 247-254, 2003
 
8) Hiroshima K, Abe S, Ebihara Y, et al : Cytological characteristics of pulmonary large cell neuroendocrine carcinoma. Lung Cancer 48 : 331-337, 2005
PubMed
9) Hoshi R, Tsuzuku M, Horai T, et al : Discriminant model for cytologic distinction of large cell neuroendocrine carcinoma from small cell carcinoma of the lung. J Thorac Oncol 5 : 472-478, 2010
 
10) Satoh Y, Hoshi R, Horai T, et al : Association of cytologic micropapillary clusters in cytology samples with lymphatic spread in clinical stage I lung adenocarcinomas. Lung Cancer 64 : 277-281, 2009
 
P.260 掲載の参考文献
1) Tanaka T, Nagai Y, Miyazawa H, et al : Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers. Cancer Sci 98 : 246-252, 2007
PubMed
2) Goto K, Satouchi M, Ishii G, et al : An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol 23 : 2914-2919, 2012
PubMed
3) Hagiwara K, Kobayashi K : Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non-small cell lung cancer. Cancer Sci 104 : 291-297, 2013
PubMed
4) Kobayashi K, Hagiwara K : Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC). Target Oncol 8 : 27-33, 2013
PubMed
5) 藤本英也, 古本奈緒美, 松田耕一郎他 : 当社におけるPNA-LNA PCR clamp法を用いたEGFR遺伝子変異解析の状況について. 病理技術 73 : 67-69, 2010
 
6) de Jonge HJM, Fehrmann RSN, deBont ESJM, et al : Evidence based selection of housekeeping genes. PLoS ONE 2 : e898, 2007
 
P.265 掲載の参考文献
1) Reck M, Heigener DF, Mok T, et al : Management of nonsmall-cell lung cancer : recent developments. Lancet 382 : 709-719, 2013
PubMed
2) Lynch TJ, Lynch TJ, Bell DW, et al : Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 : 2129-2139, 2004
PubMed
3) Soda M, Choi YL, Enomoto M, et al : Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448 : 561-566, 2007
PubMed
4) Bergethon K, Shaw AT, Ou SI, et al : ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 30 ; 863-870, 2012
 
5) Kohno T, Ichikawa H, Totoki Y, et al : KIF5B-RET fusions in lung adenocarcinoma. Nat Med 18 : 375-377, 2012
PubMed
6) Pao W, Girard N : New driver mutations in non-small-cell lung cancer. Lancet Oncol 12 : 175-180, 2011
PubMed
7) Mitsudomi T, Morita S, Yatabe Y, et al : Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405) : an open label, randomized phase 3 trial. Lancet Oncol 11 : 121-128, 2010
PubMed
8) Maemondo M, Inoue A, Kobayashi K : Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362 : 2380-2388, 2010
 
9) Zhou C, Wu YL, Chen G, et al : Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802) : a multicentre, open-label, randomised, phase 3 study. Lancet Oncol 12 : 735-742, 2011
 
10) Rosell R, Carcereny E, Gervais R, et al : Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive nonsmall-cell lung cancer (EURTAC) : a multicentre, openlabel, randomised phase 3 trial. Lancet Oncol 13 : 239-246, 2012
PubMed
11) Sequist LV, Yang JC, Yamamoto N, et al : Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J Clin Oncol 31 : 3327-3334, 2013
 
12) Wu YL, Zhou C, Hu CP, et al : LUX-Lung 6 : A randomized, open-label, phase III study of afatinib versus gemcitabine/cisplatin as first-line treatment for Asian patients with EGFR mutation-positive advanced adenocarcinoma of the lung. J Clin Oncol 31, 2013 (suppl ; abstr 8016)
 
13) NCCNガイドライン Ver2. 2014 (http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf)
 
14) Seto T, Kiura K, Nishio M, et al : CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study) : a single-arm, open-label, phase 1-2 study. Lancet Oncol 14 : 590-598, 2013
PubMed
15) Shaw AT, Kim DW, Mehra R, et al : Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med 370 : 1189-1197, 2014
PubMed
16) Nakagawa K, Hida T, Seto T, et al : Antitumor activity of alectinib (CH5424802/RO5424802) for ALK-rearranged NSCLC with or without prior crizotinib treatment in bioequivalence study. J Clin Oncol 32 : 5s, 2014 (suppl ; abstr 8103)
PubMed
17) Gadgeel SM, Gandhi L, Riely GJ, et al : Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged nonsmall-cell lung cancer (AF-002JG) : results from the dosefinding portion of a phase 1/2 study. Lancet Oncol 15 : 1119-1128, 2014,
PubMed
18) Janne PA, Ramalingam SS, Yang J, et al : Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients (pts) with EGFR inhibitor-resistant non-small cell lung cancer (NSCLC). J Clin Oncol 32 : 5s, 2014 (suppl ; abstr 8009).
 
19) Sequist LV, Soria JC, Gadgeel SM, et al : First-in-human evaluation of CO-1686, an irreversible, highly selective tyrosine kinase inhibitor of mutations of EGFR (activating and T790M). J Clin Oncol 32 : 5s, 2014 (suppl ; abstr 8010)
 
20) Janne PA, Meyerson M : ROS1 rearrangements in lung cancer : a new genomic subset of lung adenocarcinoma. J Clin Oncol 30 : 878-879, 2012
PubMed
21) Kris MG, Johnson BE, Kwiatkowski DJ, et al : Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma : The NCI's Lung Cancer Mutation Consortium (LCMC). J Clin Oncol 29, 2011 (suppl ; abstr CRA7506)
 
22) Johnson BE, Kris MG, Berry LD, et al : A multicenter effort to identify driver mutations and employ targeted therapy in patients with lung adenocarcinomas : The Lung Cancer Mutation Consortium (LCMC). J Clin Oncol 31, 2013 (suppl ; abstr 8019)
 
23) Barlesi F, Blons H, Beau-Faller M, et al : Biomarkers (BM) France : Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts). J Clin Oncol 31, 2013 (suppl ; abstr 8000)
 
24) Koh Y, Kenmotsu H, Serizawa M, et al : Identification of actionable mutations in surgically resected tumor specimens from Japanese patients with non-small cell lung cancer by ultra-deep targeted sequencing. J Clin Oncol 31, 2013 (suppl ; abstr 7572)
 
25) Scagliotti GV, Parikh P, von Pawel, et al : Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26 : 3543-3551, 2008
PubMed
26) Paz-Ares L, de Marinis, Dediu M, et al : Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT) : a double-blind, phase 3, randomised controlled trial. Lancet Oncol 13 : 247-255, 2012
PubMed
27) Socinski MA, Bondarenko I, Karaseva NA, et al : Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer : Final results of a phase III trial. J Clin Oncol 10 : 2055-2062, 2012
PubMed
28) Brahmer JR, Tykodi SS, Chow LQ, et al : Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366 : 2455-2465, 2012
PubMed
P.270 掲載の参考文献
1) Yu J, Kane S, Wu J, et al : Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer. Clin Cancer Res 15 : 3023-3028, 2009
PubMed
2) Yasuda H, Kobayashi S, Costa DB : EGFR exon 20 insertion mutations in non-small-cell lung cancer : preclinical data and clinical implications. Lancet Oncol 13 : e23-31, 2012
PubMed
3) Shaw AT, Kim DW, Nakagawa K, et al : Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368 : 2385-2394, 2013
PubMed
4) 日本肺癌学会バイオマーカー委員会 : 肺癌患者におけるALK遺伝子検査の手引き. 2011. Available at : http://www.haigan.gr.jp/modules/bulletin/index.php?page=article&storyid=41.
 
5) Camidge DR, Doebele RC : Treating ALK-positive lung cancer-early successes and future challenges. Nat Rev Clin Oncol 9 : 268-277, 2012
PubMed
P.275 掲載の参考文献
1) 日本肺癌学会EGFR 解説作成委員 : 肺癌患者におけるEGFR遺伝子変異検査の解説, 2009. Available at : http://www.haigan.gr.jp/modules/bulletin/index.php?page=article&storyid=14
 
2) 日本肺癌学会バイオマーカー委員会 : ALK遺伝子検査の手引き, 2011. Available at : http://www.haigan.gr.jp/modules/bulletin/index.php?page=article&storyid=41
 
3) Lindeman NI, Cagle PT, Beasley MB, et al : Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors : guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med 137 : 828-860, 2013
 
4) Mok TS, Wu YL, Thongprasert S, et al : Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361 : 947-957, 2009
 
5) Travis WD, Brambilla E, Noguchi M, et al : International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
6) Sauter G, Lee J, Bartlett JM, et al : Guidelines for human epidermal growth factor receptor 2 testing : biologic and methodologic considerations. J Clin Oncol 27 : 1323-1333, 2009
PubMed
7) Hirsch FR, Witta S : Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancer. Curr Opin Oncol 17 : 118-122, 2005
PubMed
P.277 掲載の参考文献
1) 下里幸雄, 井内康輝 (編) : 腫瘍鑑別診断アトラス 肺, 第2版, 文光堂, 2004
 
2) Travis WD, Brambilla E, Noguchi M, et al : International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6 : 244-285, 2011
 
P.283 掲載の参考文献
1) Sobin L, Gospodarowicz M, Wittekind Ch (eds) : UICC International Union Against Cancer ; TNM Classification of Malignant Tumours. 7th ed, Wiley-Blackwell, Oxford, 2009
 
2) 日本肺癌学会 (編) : 肺癌取扱い規約, 第7版, 金原出版, 2010
 
3) Travis WD Brambilla E Noguchi M, et al : The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 6 : 244-285, 2011
 
4) Hamasaki M, Kato F, Koga K, et al : Invasion of the inner and outer layers of the visceral pleura in pT1 size lung adenocarcinoma measuring < 3cm : correlation with malignant aggressiveness and prognosis. Virchows Arch 461 : 513-519, 2012
 

書評

最近チェックした商品履歴

Loading...